{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-041513","form_type":"8-K","ticker":null,"cik":"0001600847","company_name":"Gamida Cell Ltd.","filed_at":"2023-05-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.607992+00:00","generated_at":"2026-06-14T19:48:57.012718+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Shareholders approve increase in authorized shares from 150M to 225M ordinary shares","bullets":["Amendment to Articles of Association approved at special meeting on May 19, 2023.","Authorized share capital increased from NIS 1.5M (150M shares) to NIS 2.25M (225M shares).","Approval: 25,785,122 for, 3,160,773 against, 313,206 abstain; 34.94% quorum.","Effective upon approval; filing of amended Articles as Exhibit 3.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-041513","json":"https://secwatch.observer/filing/0001213900-23-041513.json","markdown":"https://secwatch.observer/filing/0001213900-23-041513.md","text":"https://secwatch.observer/filing/0001213900-23-041513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041513/0001213900-23-041513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041513/ea178992-8k_gamida.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T19:48:57.012718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e2ed45ccfcc3dbd26e25c0251527c024e649ce0","claim":"Gamida Cell Ltd.: Increased authorized share capital from NIS 1,500,000 divided into 150,000,000 ordinary shares to NIS 2,250,000 divided into 225,000,000 ordinary shares (effective 2023-05-19).","evidence_excerpt":"the Company’s shareholders approved an amendment to the Company’s Articles of Association (the “Articles”), effective upon approval, to increase the Company’s authorized share capital from NIS 1,500,000, divided into 150,000,000 ordinary shares, to NIS 2,250,000, divided into 225,000,000 ordinary shares.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041513/0001213900-23-041513-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-05-19"}],"fact_type":"governance_change"},{"claim_id":"a8dc38bb72c43cfcc7c96359596833942503068a","claim":"Gamida Cell Ltd. shareholders approved Increase in authorized share capital from NIS 1,500,000 divided into 150,000,000 ordinary shares to NIS 2,250,000 divided into 225,000,000 ordinary shares via amendment to Article 5.1.1 of the Articles of Association at the 2023-05-19 meeting.","evidence_excerpt":"Proposal No. 1 : The proposal to approve the increase in the Company’s authorized share capital from NIS 1,500,000, divided into 150,000,000 ordinary shares to NIS 2,250,000, divided into 225,000,000 ordinary shares via the adoption of an amendment to Article 5.1.1 of the Company’s current Articles of Association was approved by the shareholders by the votes set forth in the table below: For Against Abstain Broker Non-Votes 25,785,122 3,160,773 313,206 0","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1600847/000121390023041513/0001213900-23-041513-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-05-19"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}